Add to ORKGThe article presents a generalized 2-year Russian experience in the application of monoclonal antibodies to IgE in children and adolescents with severe, resistant to standard treatment of bronchial asthma. Data on 65 patients treated with anti-IgE therapy with omalizumab within more than 6 months period in 6 centers of the Russian Federation from 2007 to 2010 were analyzed. The results of this analysis demonstrate the safety and high clinical effectiveness of anti-IgE-therapy in children and adolescents with severe uncontrolled atopic bronchial asthma. Full control of the disease or marked improvement can be achieved in 73% patients, the effect in most cases significantly increases during the first 6 months of treatment and becomes stable i...
The article is devoted to the problem of timely diagnosis and current principles of management of ch...
Omalizumab is a humanized monoclonal antibody that is directed against IgE. It has been shown to imp...
Severe bronchial asthma in children remains a serious problem, which is due to the high risk of mort...
The article presents a generalized 2-year Russian experience in the application of monoclonal antibo...
Omalizumab, a medicine of the recombinant humanized mono clonal antibodies to Ige, is applied in rus...
Antibodies to IgE are a totally new class of medications currently used to enhance the supervision o...
The article summarizes a two-year experience of treating children and adolescents with severe uncont...
The article describes a modern approach to the use of anti-IgE therapy for allergic bronchial asthma...
The article presents the results of comprehensive assessment of the efficacy of anti-IgE therapy in ...
This article studies the specifics of allergic diseases pathogenesis. Such common allergic diseases ...
Omalizumab, whose active basis is recombinant, human, monoclonal antibodies to Ige, gives a unique t...
Severe bronchial asthma in children remains a serious problem, which is caused by high mortality, si...
Up to 22% of the population in the world suffer from bronchial asthma according to the data from dif...
Anti-IgE treatment represents a major breakthrough in the therapeutic management of severe allergic ...
In the given article, the authors discuss the most difficult issue of the pediatrics, which is the t...
The article is devoted to the problem of timely diagnosis and current principles of management of ch...
Omalizumab is a humanized monoclonal antibody that is directed against IgE. It has been shown to imp...
Severe bronchial asthma in children remains a serious problem, which is due to the high risk of mort...
The article presents a generalized 2-year Russian experience in the application of monoclonal antibo...
Omalizumab, a medicine of the recombinant humanized mono clonal antibodies to Ige, is applied in rus...
Antibodies to IgE are a totally new class of medications currently used to enhance the supervision o...
The article summarizes a two-year experience of treating children and adolescents with severe uncont...
The article describes a modern approach to the use of anti-IgE therapy for allergic bronchial asthma...
The article presents the results of comprehensive assessment of the efficacy of anti-IgE therapy in ...
This article studies the specifics of allergic diseases pathogenesis. Such common allergic diseases ...
Omalizumab, whose active basis is recombinant, human, monoclonal antibodies to Ige, gives a unique t...
Severe bronchial asthma in children remains a serious problem, which is caused by high mortality, si...
Up to 22% of the population in the world suffer from bronchial asthma according to the data from dif...
Anti-IgE treatment represents a major breakthrough in the therapeutic management of severe allergic ...
In the given article, the authors discuss the most difficult issue of the pediatrics, which is the t...
The article is devoted to the problem of timely diagnosis and current principles of management of ch...
Omalizumab is a humanized monoclonal antibody that is directed against IgE. It has been shown to imp...
Severe bronchial asthma in children remains a serious problem, which is due to the high risk of mort...